Abstract

BackgroundCommunity-associated methicillin-resistant Staphylococcus aureus-(CA-MRSA) strains have emerged in Argentina. We investigated the clinical and molecular evolution of community-onset MRSA infections (CO-MRSA) in children of Córdoba, Argentina, 2005–2008. Additionally, data from 2007 were compared with the epidemiology of these infections in other regions of the country.Methodology/Principal FindingsTwo datasets were used: i) lab-based prospective surveillance of CA-MRSA isolates from 3 Córdoba pediatric hospitals-(CBAH1-H3) in 2007–2008 (compared to previously published data of 2005) and ii) a sampling of CO-MRSA from a study involving both, healthcare-associated community-onset-(HACO) infections in children with risk-factors for healthcare-associated infections-(HRFs), and CA-MRSA infections in patients without HRFs detected in multiple centers of Argentina in 2007. Molecular typing was performed on the CA-MRSA-(n: 99) isolates from the CBAH1-H3-dataset and on the HACO-MRSA-(n: 51) and CA-MRSA-(n: 213) isolates from other regions. Between 2005–2008, the annual proportion of CA-MRSA/CA-S. aureus in Córdoba hospitals increased from 25% to 49%, P<0.01. Total CA-MRSA infections increased 3.6 fold-(5.1 to 18.6 cases/100,000 annual-visits, P<0.0001), associated with an important increase of invasive CA-MRSA infections-(8.5 fold). In all regions analyzed, a single genotype prevailed in both CA-MRSA (82%) and HACO-MRSA(57%), which showed pulsed-field-gel electrophoresis-(PFGE)-type-“I”, sequence-type-5-(ST5), SCCmec-type-IVa, spa-t311, and was positive for PVL. The second clone, pulsotype-N/ST30/CC30/SCCmecIVc/t019/PVL+, accounted for 11.5% of total CA-MRSA infections. Importantly, the first 4 isolates of Argentina belonging to South American-USA300 clone-(USA300/ST8/CC8/SCCmecIVc/t008/PVL+/ACME−) were detected. We also demonstrated that a HA-MRSA clone-(pulsotype-C/ST100/CC5) caused 2% and 10% of CA-MRSA and HACO-MRSA infections respectively and was associated with a SCCmec type closely related to SCCmecIV(2B&5).Conclusions/SignificanceThe dissemination of epidemic MRSA clone, ST5-IV-PVL+ was the main cause of increasing staphylococcal community-onset infections in Argentinean children (2003–2008), conversely to other countries. The predominance of this clone, which has capacity to express the h-VISA phenotype, in healthcare-associated community-onset cases suggests that it has infiltrated into hospital-settings.

Highlights

  • Methicillin resistant Staphylococcus aureus (MRSA) infection has traditionally been associated with healthcare settings (HA-MRSA) until its emergence in the community during late 1990’s

  • We demonstrated that a HA-MRSA clone-(pulsotype-C/ST100/CC5) caused 2% and 10% of communityassociated methicillin-resistant Staphylococcus aureus (CA-MRSA) and Healthcare-associated CO (HACO)-MRSA infections respectively and was associated with a staphylococcal cassette chromosome mec (SCCmec) type closely related to SCCmecIV(2B&5)

  • The incidence of CA-MRSA infections among children tripled over that time frame, associated with an 8.5-fold increase in invasive CA-MRSA infections, despite the almost stable overall rate of CA-MSSA infections (1.1 fold increase)

Read more

Summary

Introduction

Methicillin resistant Staphylococcus aureus (MRSA) infection has traditionally been associated with healthcare settings (HA-MRSA) until its emergence in the community during late 1990’s. That emerged from some major genetic lineages, commonly designated by their multilocus sequence type (MLST) or by their pulsed field gel electrophoresis (PFGE) pattern (ST1, ST8USA300, ST30, ST59, ST93 and ST80),with a specific geographical pattern. These strains are frequently non-multiresistant to antibiotics; most of them harbor the staphylococcal cassette chromosome mec (SCCmec) type IV(2B) or V(5C2) and the Panton-Valentine leukocidin (PVL) genes [1,2,3]. Data from 2007 were compared with the epidemiology of these infections in other regions of the country

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call